Exhibit 107
Calculation of Filing Fee Tables
S-3
(Form Type)
Plus Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Class Title(1) | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate | Fee Rate | Amount of Registration Fee(4) | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial Effective Date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |||||||||||||
| Newly Registered Securities | ||||||||||||||||||||||||
Fees to be Paid | Equity | Common Stock | Rule 457(o) | (2) | (3) | — | 0.0001531 | — | ||||||||||||||||
Fees to be Paid | Equity | Preferred Stock | Rule 457(o) | (2) | (3) | — | 0.0001531 | — | ||||||||||||||||
Fees to be Paid | Other | Warrants | Rule 457(o) | (2) | (3) | — | 0.0001531 | — | ||||||||||||||||
Fees to be Paid | Debt | Debt Securities | Rule 457(o) | (2) | (3) | — | 0.0001531 | — | ||||||||||||||||
Fees to be Paid | Other | Depositary Shares | Rule 457(o) | (2) | (3) | — | 0.0001531 | — | ||||||||||||||||
Fees to be Paid | Other | Stock Purchase Contracts | Rule 457(o) | (2) | (3) | — | 0.0001531 | — | ||||||||||||||||
Fees to be Paid | Other | Subscription Rights | Rule 457(o) | (2) | (3) | — | 0.0001531 | — | ||||||||||||||||
Fees to be Paid | Other | Units | Rule 457(o) | (2) | (3) | — | 0.0001531 | — | ||||||||||||||||
Fees to be Paid | Unallocated (Universal) Shelf | — | Rule 457(o) | (2) | (3) | $100,000,000(2) | 0.0001531 | $15,310 | ||||||||||||||||
Fees Previously Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||||||||
| Total Offering Amounts | $100,000,000(2) | $15,310 | ||||||||||||||||||||||
| Total Fees Previously Paid | — | |||||||||||||||||||||||
| Total Fee Offsets | $— | |||||||||||||||||||||||
| Net Fee Due | $15,310 | |||||||||||||||||||||||
| (1) | The securities covered by this registration statement to be sold by Plus Therapeutics, Inc. (the “Registrant”), may be sold separately or in any combination with any other securities registered under this registration statement. |
| (2) | The Registrant is registering under this registration statement the offer and sale of an unspecified number of securities of each identified class as may from time to time be issued at unspecified prices, including securities that may be issued upon exercise, conversion or exchange. Separate consideration may or may not be received for securities that are issuable on exercise, conversion or exchange of other securities. The aggregate maximum offering price of all securities offered pursuant to this registration statement shall not exceed $100,000,000. |
| (3) | The proposed maximum offering price per security and the proposed maximum aggregate offering price per class of security will be determined from time to time by the Registrant in connection with the issuance by the Registrant of the securities registered hereunder and is not specified as to each class of security pursuant to General Instruction II.D. of Form S-3 under the Securities Act of 1933, as amended (the “Securities Act”). |
| (4) | Calculated pursuant to Rule 457(o) under the Securities Act based on the proposed maximum aggregate offering price of all securities listed. |
